Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.

导出原文传递

翻译打印收藏纠错

作者： Valeria,Lucarini ^[1] ; Carla,Buccione ^[1] ; Giovanna,Ziccheddu ^[1] ; Francesca,Peschiaroli ^[1] ; Paola,Sestili ^[1] ; Rossella,Puglisi ^[1] ; Gianfranco,Mattia ^[1] ; Cristiana,Zanetti ^[1] ; Isabella,Parolini ^[1] ; Laura,Bracci ^[1] ; Iole,Macchia ^[1] ; Alessandra,Rossi ^[1] ; Maria Teresa,D'Urso ^[1] ; Daniele,Macchia ^[1] ; Massimo,Spada ^[1] ; Adele,De Ninno ^[2] ; Annamaria,Gerardino ^[2] ; Pamela,Mozetic ^[3] ; Marcella,Trombetta ^[3] ; Alberto,Rainer ^[3] ; Luca,Businaro ^[4] ; Giovanna,Schiavoni ^[1] ; Fabrizio,Mattei ^[5]

作者单位： Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. ^[1] Institute for Photonics and Nanotechnologies, Italian National Research Council, Rome, Italy. ^[2] Unit of Tissue Engineering, Università Campus Bio-Medico di Roma, via Álvaro del Portillo 21, Rome, Italy. ^[3] Institute for Photonics and Nanotechnologies, Italian National Research Council, Rome, Italy; UCBM-CNR Joint Lab for Nanotechnologies for the Life Sciences, Università Campus Bio-Medico di Roma, Rome, Italy. ^[4] Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. Electronic address: fabrizio.mattei@iss.it. ^[5]